Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
John L. Villano, Matthew Koshy, Habib Shaikh, et al.
British Journal of Cancer (2011) Vol. 105, Iss. 9, pp. 1414-1418
Open Access | Times Cited: 511

Showing 1-25 of 511 citing articles:

Primary CNS Lymphoma
Christian Grommes, Lisa M. DeAngelis
Journal of Clinical Oncology (2017) Vol. 35, Iss. 21, pp. 2410-2418
Open Access | Times Cited: 486
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
Khê Hoang‐Xuan, E.M. Bessell, Jacoline E. C. Bromberg, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 7, pp. e322-e332
Open Access | Times Cited: 391
Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Meredith S. Shiels, Ruth M. Pfeiffer, Caroline Besson, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 3, pp. 417-424
Open Access | Times Cited: 234
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
Jacoline E. C. Bromberg, Samar Issa, Katerina Bakunina, et al.
The Lancet Oncology (2019) Vol. 20, Iss. 2, pp. 216-228
Closed Access | Times Cited: 209
The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades
Joe Mendez, Quinn T. Ostrom, Haley Gittleman, et al.
Neuro-Oncology (2017) Vol. 20, Iss. 5, pp. 687-694
Open Access | Times Cited: 208
Management and outcome of primary CNS lymphoma in the modern era
Caroline Houillier, Carole Soussain, Hervé Ghesquières, et al.
Neurology (2020) Vol. 94, Iss. 10
Open Access | Times Cited: 187
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial
Antonio Omuro, Olivier Chinot, Luc Taillandier, et al.
The Lancet Haematology (2015) Vol. 2, Iss. 6, pp. e251-e259
Closed Access | Times Cited: 184
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
James L. Rubenstein, Huimin Geng, Eleanor J. Fraser, et al.
Blood Advances (2018) Vol. 2, Iss. 13, pp. 1595-1607
Open Access | Times Cited: 172
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma
Christian Grommes, James L. Rubenstein, Lisa M. DeAngelis, et al.
Neuro-Oncology (2018) Vol. 21, Iss. 3, pp. 296-305
Open Access | Times Cited: 164
Primary central nervous system lymphoma
Lauren Schaff, Christian Grommes
Blood (2021) Vol. 140, Iss. 9, pp. 971-979
Open Access | Times Cited: 132
Primary central nervous system lymphoma
Andrés J.M. Ferreri, Teresa Calimeri, Kate Cwynarski, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 88
Signaling pathways in brain tumors and therapeutic interventions
Shenglan Li, Can Wang, Jinyi Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Diagnosis and treatment of primary CNS lymphoma
Agnieszka Korfel, Uwe Schlegel
Nature Reviews Neurology (2013) Vol. 9, Iss. 6, pp. 317-327
Closed Access | Times Cited: 189
Genomic characterization of primary central nervous system lymphoma
Kazutaka Fukumura, Masahito Kawazu, Shinya Kojima, et al.
Acta Neuropathologica (2016) Vol. 131, Iss. 6, pp. 865-875
Closed Access | Times Cited: 166
How I treat CNS lymphomas
James L. Rubenstein, Neel K. Gupta, Gabriel N. Mannis, et al.
Blood (2013) Vol. 122, Iss. 14, pp. 2318-2330
Open Access | Times Cited: 165
The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle‐aged men and differs from time trends in systemic diffuse large B‐cell non‐Hodgkin's lymphoma
Brian Patrick O’Neill, Paul A. Decker, Christina Tieu, et al.
American Journal of Hematology (2013) Vol. 88, Iss. 12, pp. 997-1000
Open Access | Times Cited: 139
Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring
Carlotta Chiavazza, Alessia Pellerino, F. Ferrio, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-16
Open Access | Times Cited: 122
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma
Han W. Tun, Patrick B. Johnston, Lisa M. DeAngelis, et al.
Blood (2018) Vol. 132, Iss. 21, pp. 2240-2248
Open Access | Times Cited: 115
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group
Elisa Jacobsen Pulczynski, Outi Kuittinen, Martin Erlanson, et al.
Haematologica (2014) Vol. 100, Iss. 4, pp. 534-540
Open Access | Times Cited: 99
MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas
Naema Nayyar, Michael White, Corey M. Gill, et al.
Blood Advances (2019) Vol. 3, Iss. 3, pp. 375-383
Open Access | Times Cited: 98
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
Maher K. Gandhi, Thanh Hoang, Soi Cheng Law, et al.
Blood (2020) Vol. 137, Iss. 11, pp. 1468-1477
Open Access | Times Cited: 88
Radiomic features and multilayer perceptron network classifier: a robust MRI classification strategy for distinguishing glioblastoma from primary central nervous system lymphoma
Jihye Yun, Ji Eun Park, Hyunna Lee, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 86
Epidemiology of haematological malignancies in people living with HIV
Stephen Kimani, Matthew Painschab, Marie‐Josèphe Horner, et al.
The Lancet HIV (2020) Vol. 7, Iss. 9, pp. e641-e651
Open Access | Times Cited: 72
A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017
Esmaeil Mohammadi, Erfan Ghasemi, Sina Azadnajafabad, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0247120-e0247120
Open Access | Times Cited: 64
Evidence-based expert consensus on the management of primary central nervous system lymphoma in China
Tong Chen, Yuanbo Liu, Yang Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top